U.S. RESEARCH ROUNDUP-Microsoft, Chevron, Carisma Therapeutics

Samsara (Pre-Reincorporation)

31/05/2023 08:47

May 31 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Carisma Therapeutics, Chevron and Microsoft,
on Wednesday. 
    
    HIGHLIGHTS
                 * Carisma Therapeutics Inc  CARM.O : Jefferies assumes coverage with buy vs hold
 rating     
 
                 * Chevron Corp  CVX.N : JP Morgan raises to neutral from underweight
 
                 * Microsoft  MSFT.O : Piper Sandler raises target price to $400 from $348     
 
                 * Palomar Holdings Inc  PLMR.O : KBW raises target price to $67 from $64     
 
              
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order. 
    
                 * 23Andme Holding Co.  ME.O : TD Cowen cuts target price to $5 from $6 
 
                 * Ambarella Inc  AMBA.O : Wells Fargo cuts target price to $90 from $100 
 
                 * American Eagle Outfitters Inc  AEO.N : TD Cowen cuts target price to $12 from $15 
 
                 * Axonics Inc  AXNX.O : Jefferies cuts target price to $55 from $65 
 
                 * Carisma Therapeutics Inc  CARM.O : Jefferies assumes coverage with buy vs hold rating 
 
                 * Carisma Therapeutics Inc  CARM.O : Jefferies assumes coverage with target $7 vs $0.60
 
                 * Chemours Co  CC.N : JP Morgan cuts target price to $30 from $35 
 
                 * Chevron Corp  CVX.N : JP Morgan raises to neutral from underweight
 
                 * Chevron Corp  CVX.N : JP Morgan raises target price to $170 from $161 
 
                 * Crowdstrike Holdings Inc  CRWD.O : BTIG raises target price to $188 from $163 
 
                 * Equity Residential  EQR.N : RBC raises target price to $71 from $70 
 
                 * Galapagos NV  GLPG.N : JP Morgan cuts target price to $45 from $52 
 
                 * Greenlight Biosciences Holdings Pbc  GRNA.O : Canaccord Genuity cuts PT to $0.30 from $4 
 
                 * Greenlight Biosciences Holdings Pbc  GRNA.O : Canaccord Genuity cuts to hold from buy 
 
                 * Guidewire Software Inc  GWRE.N : D.A. Davidson raises target price to $94 from $90 
 
                 * Hewlett Packard Enterprise Co  HPE.N : Credit Suisse cuts target price to $18 from $19 
 
                 * Hibbett Inc  HIBB.O : Baird cuts target price to $50 from $70 
 
                 * Howard Hughes Corp  HHC.N : Piper Sandler cuts target price to $95 from $100 
 
                 * Hudson Pacific Properties Inc  HPP.N : Piper Sandler cuts target price to $6 from $8 
 
                 * Innovative Industrial Properties Inc  IIPR.N : Piper Sandler cuts target to $80 from $97 
 
                 * Insperity Inc  NSP.N : Baird cuts target price to $120 from $131 
 
                 * Jacobs Solutions Inc  J.N : TD Cowen cuts target price to $128 from $150 
 
                 * Lincoln Electric Holdings Inc  LECO.O : Baird raises target price to $200 from $184 
 
                 * Mastercraft Boat Holdings Inc  MCFT.O : D.A. Davidson starts with neutral rating; PT $29 
 
                 * Microsoft  MSFT.O : Piper Sandler raises target price to $400 from $348 
 
                 * Nevro Corp  NVRO.N : RBC starts with outperform rating; target price $40 
 
                 * Palomar Holdings Inc  PLMR.O : KBW raises target price to $67 from $64 
 
                 * Samsara Inc  IOT.N : RBC raises target price to $24 from $21 
 
                 * Sentinelone Inc  S.N : BTIG raises target price to $25 from $20 
 
                 * Skyline Champion Corp  SKY.N : Wedbush cuts target price to $78 from $83 
 
                 * Sotherly Hotels Inc  SOHO.O : Piper Sandler cuts target price to $2 from $2.50 
 
                 * Tronox Holdings Plc  TROX.N : JP Morgan cuts target price to $16 from $18 
 
                 * Vicarious Surgical Inc  RBOT.N : Canaccord Genuity cuts target price to $9 from $12 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))